Novartis sells global rights to Elidel®, a medicine to treat atopic dermatitis
- Details
- Category: Novartis

FDA approves orphan drug vandetanib
- Details
- Category: AstraZeneca

Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation
- Details
- Category: Sanofi

Pfizer to Sell Capsugel to KKR
- Details
- Category: Pfizer

Boehringer Ingelheim's lead hepatitis C compound moves into phase III
- Details
- Category: Boehringer Ingelheim

GSK publishes payments for research, consulting and advising by US healthcare professionals
- Details
- Category: GlaxoSmithKline

Pfizer Posts Details Of Interactions With U.S. Health Care Professionals And Researchers In 2010
- Details
- Category: Pfizer

More Pharma News ...
- REACT study to evaluate impact of Daxas® (roflumilast) in patients receiving standard COPD treatment
- Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective
- A new pharmaceutical candidate enters Lundbeck's development pipeline
- Merck and Its Employees to Donate to Japanese Relief Effort
- UK and US governments reach agreement over AstraZeneca tax matters
- GSK statement on Avodart™ (dutasteride) for prostate cancer risk reduction
- Novartis completes acquisition of majority stake in Zhejiang Tianyuan expanding vaccines presence in China